Blue Capital Inc’s Merck MRK Stock Holding History

Blue Capital Inc’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$261K	Hold	2,171	–	–	0.17%	92
2025 Q4	$229K	Buy	+2,171	New	+$204K	0.16%	81
2024 Q4	$208K	Buy	+2,087	New	+$215K	0.15%	106

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blue Capital Inc's MRK Position: Q1 2026 in Review

Blue Capital Inc held its Merck (MRK) position steady in Q1 2026 at 2,171 shares worth $261K. The position accounts for 0.17% of the portfolio, ranked #92.

Blue Capital Inc first reported a position in MRK in Q4 2024 and has held it in 3 quarters since. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Blue Capital Inc held 2,171 shares of Merck worth $261K as of Q1 2026.
Blue Capital Inc left its Merck share count unchanged in Q1 2026.
Merck made up 0.17% of Blue Capital Inc's portfolio in Q1 2026, its #92 holding.
Blue Capital Inc first reported a position in Merck in Q4 2024 and has held it in 3 quarters since.
3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Blue Capital Inc's 13F filing for Q1 2026, filed 24 Apr 2026.